- Home
- ZYME vs ECO Comparison
ZYME vs ECO Comparison
Compare ZYME & ECO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ZYME | ECO |
|---|---|---|
| Founded | 2003 | 2018 |
| Country | United States | Greece |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 1.7B |
| IPO Year | 2022 | 2023 |
Fundamental Metrics
Financial Performance| Metric | ZYME | ECO |
|---|---|---|
| Price | $23.40 | $46.42 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 11 | 2 |
| Target Price | $38.90 | ★ $42.00 |
| AVG Volume (30 Days) | ★ 649.0K | 539.2K |
| Earning Date | 03-02-2026 | 02-18-2026 |
| Dividend Yield | N/A | ★ 7.04% |
| EPS Growth | ★ 33.33 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $105,965,000.00 | N/A |
| Revenue This Year | $162.82 | $16.07 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $18.60 |
| Revenue Growth | ★ 38.87 | N/A |
| 52 Week Low | $9.03 | $17.91 |
| 52 Week High | $28.49 | $57.29 |
Technical Indicators
Market Signals| Indicator | ZYME | ECO |
|---|---|---|
| Relative Strength Index (RSI) | 47.53 | 48.93 |
| Support Level | $22.28 | $43.51 |
| Resistance Level | $23.66 | $57.29 |
| Average True Range (ATR) | 1.36 | 1.79 |
| MACD | -0.08 | -0.68 |
| Stochastic Oscillator | 16.70 | 31.07 |
Price Performance
Historical ComparisonAbout ZYME Zymeworks Inc.
Zymeworks Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development and commercialization of next-generation multifunctional biotherapeutics. Its suite of therapeutic platforms and its fully integrated drug development engine enables precise engineering of differentiated therapeutic product candidates. Its clinical candidate, zanidatamab, is a novel HER2-targeted bispecific antibody currently being evaluated in multiple Phase 1, Phase 2, and pivotal clinical trials globally as a targeted treatment option for patients with solid tumors that express HER2. It is also advancing a deep preclinical pipeline in oncology and other therapeutic areas.
About ECO Okeanis Eco Tankers Corp.
Okeanis Eco Tankers Corp owns and operates tanker vessels in Greece. The business of the company is to own, charter out, and operate tanker vessels. The company owns, through its vessel-owning subsidiaries, a fleet of around seven tanker vessels and has around eight tanker vessels on order. The sailing fleet consists of around six modern Suezmax tankers and eight VLCC tankers.